captopril has been researched along with guaifenesin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Châtelain, C; Lacroix, JS; Pochon, N | 1 |
1 review(s) available for captopril and guaifenesin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for captopril and guaifenesin
Article | Year |
---|---|
Functional effects of phosphoramidon and captopril on exogenous neuropeptides in human nasal mucosa.
Topics: Adult; Airway Resistance; Blood Flow Velocity; Calcitonin Gene-Related Peptide; Captopril; Drug Synergism; Endothelium, Vascular; Glycopeptides; Humans; Laser-Doppler Flowmetry; Middle Aged; Mucus; Nasal Mucosa; Neprilysin; Peptidyl-Dipeptidase A; Protease Inhibitors; Substance P; Time Factors; Vasoactive Intestinal Peptide | 1995 |